Literature DB >> 848931

In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.

I Roy, V Bach, H Thadepalli.   

Abstract

A total of 334 clinical anaerobic isolates were tested in an anaerobic glove box by the agar dilution technique for susceptibility to clinically achievable levels of ticarcillin, carbenicillin, and penicillin. Thirty-two micrograms or less of penicillin per milliliter inhibited 91% of all strains, whereas 100 mug of carbenicillin and ticarcillin per ml inhibited 95 and 98%, respectively. A total of 82% (85 strains) of Bacteroides were inhibited by penicillin, and 93 and 96% were inhibited by carbenicillin and ticarcillin, respectively. Thirteen (24%) of 55 strains of Bacteroides fragilis tested were resistant to 32 mug of penicillin per ml, and 6 (11%) and 3 (5%) were resistant to 100 mug of carbenicillin and ticarcillin per ml, respectively. Within the therapeutic range, ticarcillin was the most effective of the three penicillins tested against B. fragilis subsp. fragilis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 848931      PMCID: PMC351964          DOI: 10.1128/AAC.11.2.258

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Clinical and laboratory investigations on ticarcillin, an anti-pseudomonal antibiotic.

Authors:  R Wise; D S Reeves
Journal:  Chemotherapy       Date:  1974       Impact factor: 2.544

2.  [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].

Authors:  C Simon; M Leuth; V Malerczyk
Journal:  Dtsch Med Wochenschr       Date:  1974-11-29       Impact factor: 0.628

3.  Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin.

Authors:  H C Neu; G J Garvey
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

4.  Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

Authors:  V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

5.  Ticarcillin therapy of infections.

Authors:  V Rodriguez; G P Bodey; N Horikoshi; J Inagaki; K B McCredie
Journal:  Antimicrob Agents Chemother       Date:  1973-10       Impact factor: 5.191

  5 in total
  13 in total

1.  Susceptibility of anaerobic bacteria to cofoxitin and related compounds.

Authors:  V T Bach; I Roy; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1977-05       Impact factor: 5.191

2.  In vitro activity of pipecolic acid amide of clindamycin (U-57930E) on anaerobic bacteria compared with those of clindamycin, cefoxitin, and chloramphenicol.

Authors:  V K Dhawan; M B Bansal; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

3.  Therapeutic evaluation of difloxacin (A-56619) and A-56620 for experimentally induced Bacteroides fragilis-associated intra-abdominal abscess.

Authors:  H Thadepalli; S V Gollapudi; S K Chuah
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

Authors:  M B Bansal; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

5.  In vitro activity of cefaclor against aerobic and anaerobic bacteria.

Authors:  V T Bach; M M Khurana; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

6.  In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.

Authors:  R H Prabhala; H Thadepalli; B Rao; M B Bansal; R Marshall
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 7.  Antimicrobial drugs used in the management of anaerobic infections in children.

Authors:  I Brook
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

8.  Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates.

Authors:  L G Reimer; S Mirrett; L B Reller
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

Review 9.  Ticarcillin: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-11       Impact factor: 9.546

10.  In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).

Authors:  R H Prabhala; B Rao; R Marshall; M B Bansal; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.